FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200000937> ?p ?o ?g. }

• W4200000937 endingPage "1218" @default.
• W4200000937 startingPage "1208" @default.
• W4200000937 abstract "We present a novel approach for first-in-human (FIH) dose selection of the CD20xCD3 bispecific antibody, glofitamab, based on pharmacokinetic/pharmacodynamic (PKPD) assessment in cynomolgus monkeys to select a high, safe starting dose, with cytokine release (CR) as the PD endpoint. Glofitamab pharmacokinetics were studied in mice and cynomolgus monkeys; PKPD of IL-6, TNF-α and interferon-γ release following glofitamab, with/without obinutuzumab pretreatment (Gpt) was studied in cynomolgus monkeys. Potency differences for CR between cynomolgus monkeys and humans were determined by glofitamab incubation in whole blood of both species. The PKPD model for CR was translated to humans to project a starting dose that did not induce CR exceeding a clinically-predefined threshold. In cynomolgus monkeys, glofitamab showed a species-specific atypical high clearance, with and without B-cell debulking by Gpt. CR was related to glofitamab serum levels and B-cell counts. B-cell reduction by Gpt led to a marked decrease in CR. FIH starting dose (5 µg) was selected based on IL-6 release considering the markedly higher glofitamab in vitro potency in human vs monkey blood. This is a novel PKPD-based approach for selection of FIH starting dose for a CD20xCD3 bispecific antibody in B-cell lymphoma, evidenced in the glofitamab study, NP30179 (NCT03075696)." @default.
• W4200000937 created "2021-12-31" @default.
• W4200000937 creator A5002292400 @default.
• W4200000937 creator A5005030023 @default.
• W4200000937 creator A5030144835 @default.
• W4200000937 creator A5031124710 @default.
• W4200000937 creator A5032847382 @default.
• W4200000937 creator A5035594198 @default.
• W4200000937 creator A5048684851 @default.
• W4200000937 creator A5052927788 @default.
• W4200000937 creator A5060884782 @default.
• W4200000937 creator A5080129940 @default.
• W4200000937 creator A5090819989 @default.
• W4200000937 date "2022-04-01" @default.
• W4200000937 modified "2023-10-05" @default.
• W4200000937 title "Novel in Vivo and in Vitro Pharmacokinetic/Pharmacodynamic-Based Human Starting Dose Selection for Glofitamab" @default.
• W4200000937 cites W1555185942 @default.
• W4200000937 cites W1895049594 @default.
• W4200000937 cites W1969070105 @default.
• W4200000937 cites W1970171471 @default.
• W4200000937 cites W2040016931 @default.
• W4200000937 cites W2055886080 @default.
• W4200000937 cites W2067933166 @default.
• W4200000937 cites W2069064970 @default.
• W4200000937 cites W2080195063 @default.
• W4200000937 cites W2084647551 @default.
• W4200000937 cites W2084691406 @default.
• W4200000937 cites W2090796133 @default.
• W4200000937 cites W2091057822 @default.
• W4200000937 cites W2120319857 @default.
• W4200000937 cites W2162166897 @default.
• W4200000937 cites W2170179543 @default.
• W4200000937 cites W2279127916 @default.
• W4200000937 cites W2610167700 @default.
• W4200000937 cites W2742627598 @default.
• W4200000937 cites W2750397337 @default.
• W4200000937 cites W2752698292 @default.
• W4200000937 cites W2761878534 @default.
• W4200000937 cites W2762769547 @default.
• W4200000937 cites W2802559042 @default.
• W4200000937 cites W2808166290 @default.
• W4200000937 cites W2971490864 @default.
• W4200000937 cites W2990616783 @default.
• W4200000937 cites W3008372121 @default.
• W4200000937 cites W3097623804 @default.
• W4200000937 cites W3137447968 @default.
• W4200000937 doi "https://doi.org/10.1016/j.xphs.2021.12.019" @default.
• W4200000937 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34953862" @default.
• W4200000937 hasPublicationYear "2022" @default.
• W4200000937 type Work @default.
• W4200000937 citedByCount "7" @default.
• W4200000937 countsByYear W42000009372022 @default.
• W4200000937 countsByYear W42000009372023 @default.
• W4200000937 crossrefType "journal-article" @default.
• W4200000937 hasAuthorship W4200000937A5002292400 @default.
• W4200000937 hasAuthorship W4200000937A5005030023 @default.
• W4200000937 hasAuthorship W4200000937A5030144835 @default.
• W4200000937 hasAuthorship W4200000937A5031124710 @default.
• W4200000937 hasAuthorship W4200000937A5032847382 @default.
• W4200000937 hasAuthorship W4200000937A5035594198 @default.
• W4200000937 hasAuthorship W4200000937A5048684851 @default.
• W4200000937 hasAuthorship W4200000937A5052927788 @default.
• W4200000937 hasAuthorship W4200000937A5060884782 @default.
• W4200000937 hasAuthorship W4200000937A5080129940 @default.
• W4200000937 hasAuthorship W4200000937A5090819989 @default.
• W4200000937 hasConcept C111113717 @default.
• W4200000937 hasConcept C112705442 @default.
• W4200000937 hasConcept C150903083 @default.
• W4200000937 hasConcept C159654299 @default.
• W4200000937 hasConcept C185592680 @default.
• W4200000937 hasConcept C202751555 @default.
• W4200000937 hasConcept C203014093 @default.
• W4200000937 hasConcept C207001950 @default.
• W4200000937 hasConcept C55493867 @default.
• W4200000937 hasConcept C57992300 @default.
• W4200000937 hasConcept C71924100 @default.
• W4200000937 hasConcept C86803240 @default.
• W4200000937 hasConcept C98274493 @default.
• W4200000937 hasConceptScore W4200000937C111113717 @default.
• W4200000937 hasConceptScore W4200000937C112705442 @default.
• W4200000937 hasConceptScore W4200000937C150903083 @default.
• W4200000937 hasConceptScore W4200000937C159654299 @default.
• W4200000937 hasConceptScore W4200000937C185592680 @default.
• W4200000937 hasConceptScore W4200000937C202751555 @default.
• W4200000937 hasConceptScore W4200000937C203014093 @default.
• W4200000937 hasConceptScore W4200000937C207001950 @default.
• W4200000937 hasConceptScore W4200000937C55493867 @default.
• W4200000937 hasConceptScore W4200000937C57992300 @default.
• W4200000937 hasConceptScore W4200000937C71924100 @default.
• W4200000937 hasConceptScore W4200000937C86803240 @default.
• W4200000937 hasConceptScore W4200000937C98274493 @default.
• W4200000937 hasFunder F4320309432 @default.
• W4200000937 hasIssue "4" @default.
• W4200000937 hasLocation W42000009371 @default.
• W4200000937 hasLocation W42000009372 @default.
• W4200000937 hasOpenAccess W4200000937 @default.
• W4200000937 hasPrimaryLocation W42000009371 @default.
• W4200000937 hasRelatedWork W1998587742 @default.

• next